Eli Lilly (LLY) EBIT (2009 - 2026)
Eli Lilly's EBIT was $11.75 billion in Q2 2026, up 67.4% from $7.02 billion a year earlier and up 23.7% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EBIT was $38.18 billion through Jun 30, 2026, up 73.7% year-over-year; for FY2025, it came in at $29.21 billion, up 80.6% from FY2024.
- EBIT has now increased for five consecutive years, with a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
- In earlier years, EBIT was $16.18 billion in FY2024 (+57.7%), $10.26 billion in FY2023 (+27.6%), $8.04 billion in FY2022 (+9.7%) and $7.33 billion in FY2021 (+7.3%).
- The Q2 2026 figure marks the highest quarterly EBIT in data going back to Q1 2009.
- Compared with a year earlier, EBIT has increased for 13 straight quarters, with growth averaging 73.2% over the last eight quarters.
- The best year-over-year quarter for EBIT over five years was Q1 2025 (growth of 101.1%); the worst was Q1 2023 (a decline of 37.8%).
- Per Business Quant data, LLY's EBIT in the three quarters before Q2 2026 was $9.5 billion (Q1 2026), $8.9 billion (Q4 2025) and $8.02 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.75 Bn |
| Mar 31, 2026 | 9.50 Bn |
| Dec 31, 2025 | 8.90 Bn |
| Sep 30, 2025 | 8.02 Bn |
| Jun 30, 2025 | 7.02 Bn |
| Mar 31, 2025 | 5.27 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.35 Bn |
| Jun 30, 2024 | 3.87 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 3.01 Bn |
| Sep 30, 2023 | 3.43 Bn |
| Jun 30, 2023 | 2.22 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 2.06 Bn |
API Access
Eli Lilly EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();